Feb 15, 2024 / 01:30PM GMT
Operator
Good day, and welcome to the Ironwood Pharmaceuticals fourth quarter and full-year 2023 investor update Call. (Operator Instructions). And finally, I would like to advise all participants that this call is being recorded. Thank you.
I'd now like to welcome Matt Roache, Director of Investor Relations, to begin the conference. Matt, over to you.
Matt Roache - Ironwood Pharmaceuticals Inc - Director, Investor Relations
Thank you, Gavin. Good morning, and thanks for joining us for our fourth quarter and full-year 2023 investor update. Our press release issued this morning can be found on our website. Today's call and accompanying slides include forward-looking statements. Such statements involve risks and uncertainties that may cause actual results to differ materially. A discussion of these statements and risk factors is available on the current Safe Harbor statement slide as well as under the heading Risk Factors in our annual report on Form 10-K for the year ended December 31, 2022, and our quarterly report on Form 10-Q for the quarters ended June 30,
Q4 2023 Ironwood Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot